K. Reiter

The target landscape of clinical kinase drugs

Heiner Koch, B. Kuster, R. Preissner, 2017, Science.

Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemia

W. Hiddemann, K. Metzeler, H. Leonhardt, 2017, Leukemia.

The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor

W. Hiddemann, K. Metzeler, H. Polzer, 2016, Scientific Reports.

ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation

W. Hiddemann, K. Metzeler, S. Bohlander, 2016, Nature Communications.